Fiduciary Alliance’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.6M Sell
74,707
-5,084
-6% -$1.01M 1.06% 14
2026
Q1
$15.3M Sell
79,791
-18,818
-19% -$3.26M 0.92% 18
2025
Q4
$17.5M Buy
98,609
+3,806
+4% +$635K 1.14% 13
2025
Q3
$15.1M Sell
94,803
-3,683
-4% -$544K 1.01% 18
2025
Q2
$13.9M Sell
98,486
-17,195
-15% -$2.11M 1.03% 18
2025
Q1
$13.5M Buy
115,681
+18,658
+19% +$2.4M 1.33% 13
2024
Q4
$12.2M Buy
97,023
+3,735
+4% +$460K 1.23% 14
2024
Q3
$9.72M Buy
93,288
+10,773
+13% +$1.08M 1.29% 19
2024
Q2
$8.22M Buy
82,515
+5,751
+7% +$547K 1.33% 20
2024
Q1
$7.18M Sell
76,764
-1,523
-2% -$134K 1.27% 24
2023
Q4
$7.3M Sell
78,287
-8,622
-10% -$690K 1.44% 22
2023
Q3
$7.1M Buy
86,909
+2,097
+2% +$182K 1.64% 17
2023
Q2
$7.24M Buy
84,812
+17,066
+25% +$1.46M 1.56% 20
2023
Q1
$5.95M Buy
67,746
+6,544
+11% +$611K 1.49% 21
2022
Q4
$5.2M Buy
+61,202
New +$5.22M 1.35% 22

Other funds holding MS

Fiduciary Alliance's MS Position: Q2 2026 in Review

Fiduciary Alliance reduced its Morgan Stanley (MS) stake by 6.4% in Q2 2026, selling an estimated $1.01M and leaving 74,707 shares worth $15.6M. The position accounts for 1.06% of the portfolio, ranked #14.

Fiduciary Alliance first reported a position in MS in Q4 2022 and has held it in 15 quarters since. The position peaked at $17.5M in Q4 2025. 873 funds tracked by Wall St. Rank hold MS as of Q2 2026.

  • Fiduciary Alliance held 74,707 shares of Morgan Stanley worth $15.6M as of Q2 2026.
  • Fiduciary Alliance sold 5,084 Morgan Stanley shares in Q2 2026, an estimated $1.01M.
  • Morgan Stanley made up 1.06% of Fiduciary Alliance's portfolio in Q2 2026, its #14 holding.
  • Fiduciary Alliance first reported a position in Morgan Stanley in Q4 2022 and has held it in 15 quarters since.
  • Fiduciary Alliance's Morgan Stanley position peaked at $17.5M in Q4 2025.
  • 873 funds tracked by Wall St. Rank held Morgan Stanley as of Q2 2026.

Based on Fiduciary Alliance's 13F filing for Q2 2026, filed 20 Jul 2026.